Corporate News 09-Oct-20
CreditAccess Grameen allots 1.13 cr equity shares under QIP issue
CreditAccess Grameen has allotted 1,13,15,323 Equity Shares of face value Rs 10 each to eligible qualified institutional buyers at the issue price of Rs 707 per Equity Share (including a premium of Rs 697 per Equity Share) which is at a discount of 0.1 % (i.e. Rs 0.69 per Equity Share) against the floor price of Rs 707.69 per Equity Share, aggregating to Rs 799.99 crore, pursuant to the issue.
Previous News
CreditAccess Grameen allots 25,897 equity shares under ESOP
( Corporate News - 08-Dec-23 18:00 )
CreditAccess Grameen's AUM cross Rs 25,000 cr
( Corporate News - 26-Feb-24 09:05 )
CreditAccess Grameen schedules board meeting
( Corporate News - 11-Jul-24 09:30 )
CreditAccess Grameen update on public issue of NCDs
( Corporate News - 09-Nov-22 12:27 )
CreditAccess Grameen concludes its maiden public issue of NCDs of Rs 500 cr
( Corporate News - 25-Nov-22 17:57 )
CreditAccess Grameen Q2 PAT Soars 99% YoY to Rs 349 cr
( Hot Pursuit - 21-Oct-23 12:28 )
CreditAccess Grameen consolidated net profit rises 98.14% in the September 2023 quarter
( Results - Announcements 20-Oct-23 18:04 )
CreditAccess Grameen consolidated net profit rises 170.62% in the September 2022 quarter
( Results - Announcements 22-Oct-22 08:03 )
CreditAccess Grameen consolidated net profit declines 19.74% in the September 2021 quarter
( Results - Announcements 10-Nov-21 08:09 )
CreditAccess Grameen to raise Rs 1,000 crore through NCDs
( Other Markets - Debt Markets 24-Aug-23 15:05 )
CreditAccess Grameen allots 9978 equity shares under ESOP
( Corporate News - 06-Oct-21 16:46 )
Other Stories
360 ONE WAM grants 21.47 lakh stock options
05-Oct-24 11:32
CARE reaffirms ratings on bank facilities of PNC Infratech's subsidiaries
05-Oct-24 10:45
CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
05-Oct-24 10:30
MMP Industries to convene board meeting
05-Oct-24 10:23
Mahindra & Mahindra Financial Serv. to discuss results
05-Oct-24 10:23
Ambey Laboratories to hold board meeting
05-Oct-24 10:23
Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
05-Oct-24 10:21
Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
05-Oct-24 10:19
Just Dial announces board meeting date
05-Oct-24 10:11
L&T Finance schedules board meeting
05-Oct-24 10:11
Back
Top
